- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07655765
The Effect of Breastfeeding Education Using the Pecha Kucha Technique on Breastfeeding Self-Efficacy and Breastfeeding Success in the Early Postpartum Period: A Randomized Controlled Trial
13 juin 2026 mis à jour par: YASEMİN AYDIN KARTAL, Saglik Bilimleri Universitesi
Breast milk is considered the most biologically appropriate source of nutrition, essential for the healthy growth and development of newborns.
Thanks to its optimal nutrients, immunological factors, and growth regulators, it not only meets nutritional needs but also protects against infections, reducing neonatal morbidity and mortality rates.
The Pecha Kucha presentation technique keeps presentations concise and dynamic, creating a fast-paced, light, and engaging experience.
It minimizes distractions and maximizes engagement.
Because there is no text to read in the Pecha Kucha technique, presenters are required to be more prepared and strive to create a coherent narrative, resulting in a flawless narrative.
Thus, the aim is to ensure the success and effectiveness of breastfeeding education with this technique, and ultimately, to promote breastfeeding education using the Pecha Kucha technique to healthcare professionals.
The population of this randomized, controlled experimental study consists of primiparous postpartum women who gave birth in the Obstetrics Department of the Physical Therapy Annex Building of the Gaziosmanpaşa Training and Research Hospital at the University of Health Sciences.
A power analysis was conducted using the G*Power package program, Version 3.1.9.4, to determine the sample size of the study.
Because no similar research was found in the literature, Cohen's medium effect size was chosen as the effect size, anticipating that tests assessing the difference between two independent groups would be used when examining the differences in variables between the control and intervention groups.
Accordingly, with 64 participants in the control group and 64 in the intervention group, a power of 80% was calculated at a significance level of 0.5 (medium) effect size and 0.05, and a minimum sample size of 128 was determined.
The study, planned using an experimental design, is planned to be conducted on two groups: an intervention and a control group.
Within the scope of the study, pretest data will be collected by administering the Breastfeeding Self-Efficacy Scale and the LATCH Breastfeeding Diagnostic and Assessment Scale, along with an introductory information form, to postpartum women who agree to participate in the study.
Aperçu de l'étude
Statut
Pas encore de recrutement
Les conditions
Intervention / Traitement
Type d'étude
Interventionnel
Inscription (Estimé)
128
Phase
- N'est pas applicable
Contacts et emplacements
Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.
Coordonnées de l'étude
- Nom: Yasemin, AYDIN KARTAL, Prof. Dr.
- Numéro de téléphone: (0216) 777 87 77
- E-mail: yasemin.aydin@sbu.edu.tr
Sauvegarde des contacts de l'étude
- Nom: Merve N KAYADUMAN, Midwife
- Numéro de téléphone: (0216) 777 87 77
- E-mail: merve.kydmn@gmail.com
Lieux d'étude
-
-
-
Istanbul, Turquie (Türkiye)
- Sağlık Bilimleri Üniversitesi, İstanbul,
-
Contact:
- Merve N KAYADUMAN, Midwife
- Numéro de téléphone: (0216) 777 87 77
- E-mail: merve.kydmn@gmail.com
-
-
Critères de participation
Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.
Critère d'éligibilité
Âges éligibles pour étudier
- Enfant
- Adulte
- Adulte plus âgé
Accepte les volontaires sains
Oui
La description
Inclusion Criteria:
- - Being primiparous
- Having a full-term, singleton birth
- Having a healthy newborn
- Having a spontaneous vaginal birth
Exclusion Criteria:
- Being multiparous (having given birth more than once)
- Having given birth preterm or postterm
- Having a mother or newborn with health problems
- Having had a multiple pregnancy
- Having had a cesarean section
Plan d'étude
Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Autre
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Double
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: intervention group
Mothers in the intervention group will receive breastfeeding training using the Pecha Kucha presentation technique at the first hour postpartum
|
Training will be provided using training material consisting of 20 slides, each lasting 20 seconds, prepared using the 'Pecha Kucha' technique, for a total duration of 6 minutes and 20 seconds.
|
|
Aucune intervention: control group
Standard breastfeeding education, as part of the routine postpartum care practices of the Ministry of Health, will be given to the puerperal women in the control group at the first hour postpartum.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
introductory information form
Délai: 10 minitus
|
This form, created by researchers based on literature, includes questions about the participants' age, high school graduation, their self-sufficiency against disasters, etc.
|
10 minitus
|
|
Breastfeeding Self-Efficacy Scale
Délai: 10 minutes
|
The Breastfeeding Self-Efficacy Scale was developed by the National Institutes of Health (NIH) to assess mothers' breastfeeding self-efficacy levels.
The initial form consisted of 33 items.
In 2003, the scale was shortened to a 14-item version.Dennis recommends using the short form.
The Breastfeeding Self-Efficacy Short Form Scale is a 5-point Likert-type scale (1 = Not at all confident and 5 = Always confident).
The lowest possible score is 14, and the highest is 70.
As the score increases, breastfeeding self-efficacy also increases.
The validity and reliability of the scale in Turkey were conducted by Aluş Tokat, Okumus, and Dennis (2010).
The scale is a 5-point Likert-type scale, with scores ranging from Not at all confident (1 point) to Always confident (5 points).
The minimum possible score is 14, and the maximum score is 70.
There is no cut-off point for the scale.
A higher score indicates higher breastfeeding self-efficacy.
The Cronbach's alpha for the scale was found to be0.87
|
10 minutes
|
|
Latch Breastfeeding Diagnostic and Assessment Scale
Délai: 10 minutes
|
The LATCH Breastfeeding Diagnostic Measurement Tool was developed by Jensen and colleagues (1994).
LATCH is a diagnostic tool created by simulating the Apgar scoring system in terms of its scoring method.
It is a quick and easy scale to evaluate (Jensen, Wallace 1994).
The Turkish validation of the tool was conducted by Demirhan in 1997, Koyun in 2001, and Yenal and Okumuş in 2003, and it was recommended as a reliable tool.
The lowest score obtained from the scale is 0, and the highest is 10.
A higher score indicates breastfeeding success.
The Cronbach's alpha value of the LATCH Breastfeeding Diagnostic Measurement Tool was found to be 0.95 by Yenal and Okumuş.
|
10 minutes
|
Collaborateurs et enquêteurs
C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.
Parrainer
Dates d'enregistrement des études
Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.
Dates principales de l'étude
Début de l'étude (Estimé)
13 juin 2026
Achèvement primaire (Estimé)
1 juillet 2026
Achèvement de l'étude (Estimé)
1 décembre 2026
Dates d'inscription aux études
Première soumission
13 juin 2026
Première soumission répondant aux critères de contrôle qualité
13 juin 2026
Première publication (Réel)
18 juin 2026
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
18 juin 2026
Dernière mise à jour soumise répondant aux critères de contrôle qualité
13 juin 2026
Dernière vérification
1 juin 2026
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- SBU-AYDINKARTAL-KAYADUMAN
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
NON
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Non
Étudie un produit d'appareil réglementé par la FDA américaine
Non
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .